| Literature DB >> 33298051 |
Gerhard Schmalz1, Jens Garbade2, Otto Kollmar3, Dirk Ziebolz4.
Abstract
BACKGROUND: The physical oral health and dental behaviour of patients after solid organ transplantation (SOT) has repeatedly been reported as insufficient. The objective of this systematic review was to detect whether the oral health-related quality of life (OHRQoL) of patients after SOT is reduced compared to that of healthy individuals.Entities:
Keywords: Oral health; Oral health-related quality of life; Solid organ transplantation
Year: 2020 PMID: 33298051 PMCID: PMC7726902 DOI: 10.1186/s12903-020-01350-w
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
Fig. 1PRISMA diagram reflecting the study selection during the systematic review [42]
Quality assessment of the included studies following the Agency for Healthcare Research and Quality (ARHQ) methodology checklist [20]
| Item | Segura-Saint-Gerons et al. [ | Schmalz et al. [ | Schmalz et al. [ | Schmalz et al. [ | Ruokonen et al. [ | Schmalz et al. [ | Oduncuoğlu et al. [ |
|---|---|---|---|---|---|---|---|
| 1) Define the source of information (survey, record review) | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 2) List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 3) Indicate time period used for identifying patients | No | No | Yes | No | Yes | No | Yes |
| 4) Indicate whether or not subjects were consecutive if not population-based | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 5) Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants | No | No | No | No | No | No | No |
| 6) Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements) | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 7) Explain any patient exclusions from analysis | NA | NA | NA | NA | Yes | NA | NA |
| 8) Describe how confounding was assessed and/or controlled | Yes | U | U | U | U | Yes | Yes |
| 9) If applicable, explain how missing data were handled in the analysis | NA | NA | NA | NA | NA | NA | NA |
| 10) Summarize patient response rates and completeness of data collection | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 11) Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained | NA | NA | NA | NA | Yes | NA | NA |
| Total score | 6 | 5 | 6 | 5 | 8 | 6 | 7 |
Overview of the study-specific parameters of the included studies. Values are presented as the mean values ± standard deviation, mean values (range) or percentages
| Author, year | Treatment | Country | No. of patients | Study type | Subjects mean age in years | Time since Tx | Female (%) | Control group for OHRQoL | |
|---|---|---|---|---|---|---|---|---|---|
| HC | preTx | ||||||||
| Segura-Saint-Gerons et al. [ | HTx | Spain | 150 | Monocentric cross-sectional | 54.94 ± 14.56 | 30.7% < 5 years, 32% 5–10 years, 37.3% > 10 years | 21.3% | No | No |
| Schmalz et al. [ | KTx | Germany | 39 | Multicentric cross-sectional | 56.51 ± 11.56 | n/a | 51.3% | Yes, n = 91, age: 58.31 ± 9.91 years, 65.9% female | Yes, HD n = 87, 37.9% Female, age: 60.98 ± 14.01 |
| Schmalz et al. [ | LuTx | Germany | 60 | Monocentric cross-sectional | 54.03 ± 9.97 | > 6 years: 58.3% | 50% | Yes, n = 70, age: 55.44 ± 8.54 years, 63% female | No |
| Schmalz et al. [ | LTx | Germany | 47 | Monocentric cross-sectional | 46.6 ± 12.6 | 4.7 ± 3.9 years | 42.6% | Yes, n = 75, 58.7% female, 57.1 ± 9.9 | Yes, preLTx n = 24, 41.7% female, 54.4 ± 9.5 years |
| Ruokonen et al. [ | KTx | Finland | 51 | Prospective observational | 61 (31–86) | 7.1 (1–11) years | 33% | No | Yes, predialysis n = 144, 32.6% female, age 23–83 years |
| Schmalz et al. [ | HTx | Germany | 104 | Monocentric cross-sectional | 55.26 ± 12.16 | 6.8 ± 5.16 years | 25% | No | Yes, HI n = 82, 54.90 ± 11.14 years, 15.9% female |
| Oduncuoğlu et al. [ | KTx | Turkey | 64 | Monocentric cross-sectional | 37.90 ± 10.30 | 1 year 18.8%, < 1–5 years 45.3%, > 5 years 35.9% | 31.2% | Yes, n = 61, 37.10 ± 13.41, 65.6% female | Yes, HD n = 63, 40.98 ± 9.99 years, 38.1% female |
OHRQoL oral health-related quality of life, n/a: not applicable, HD haemodialysis, HI heart insufficiency
Examined oral health parameters and the main results of oral conditions if they were presented as the mean values ± standard deviation, means (range) or percentages in the included studies
| Author, year | Tooth loss, remaining teeth, dentures | Dental diseases, caries, dental treatment need | Oral hygiene indices | Periodontal parameters, periodontal treatment need | Further oral health parameters |
|---|---|---|---|---|---|
| Segura-Saint-Gerons et al. [ | 38% denture wearing | n/a | n/a | n/a | n/a |
| Schmalz et al. [ | M-T: 7.15 ± 6.21* | DMF-T: 17.41 ± 5.51, D-T 0.74 ± 0.43, F-T: 9.51 ± 4.23 | n/a | 87.2% Moderate to severe periodontitis | n/a |
| Schmalz et al. [ | M-T: 8.17 ± 5.82* | DMF-T: 20.53 ± 5.09, D-T: 0.82 ± 1.85, F-T 11.55 ± 4.57 | n/a | 98% Moderate to severe periodontitis | n/a |
| Schmalz et al. [ | M-T: 9.5 ± 5.6* | DMF-T: 21.6 ± 5.2, D-T: 1.5 ± 2.2, F-T 11.55 ± 4.57 | n/a | 74.5% moderate to severe periodontitis | n/a |
| Ruokonen et al. [ | Remaining teeth: 21.7 ± 6.8 | n/a | n/a | n/a | Xerostomia 40%, UWSF 0.32, SWSF: 0.95 |
| Schmalz et al. [ | M-T: 6.90 ± 7.27 | DMF-T: 16.08 ± 7.11, dental treatment need: 16.3% | n/a | Periodontal treatment need: 85.6% | n/a |
| Oduncuoğlu et al. [ | M-T: 3.69 ± 5.39** | DMF-T: 5.2 ± 5.8, D-T: 1.0 ± 1.62, F-T: 0.63 ± 1.52 | GI: 1.33 ± 0.33, PI: 1.68 ± 0.4 | PPD: 2.48 ± 0.6 | n/a |
M-T missing teeth, D-T decayed teeth, F-T filled teeth, DMF-T decayed-, missing- and filled teeth index, PI plaque index, GI gingival index, PPD periodontal probing depth, UWS unstimulated whole saliva, SWS stimulated whole saliva, n/a not applicable
*inclusion criterion: at least 6 remaining teeth
** inclusion criterion: at least 10 remaining teeth
Applied assessments for OHRQoL and relevant results for the included studies
| Author, year | Assessment of OHRQoL | OHRQoL different compared to control | Association/correlation between OHRQoL and general HRQoL | Association/correlation between OHRQoL and oral health | Association and/or correlation between OHRQoL and disease-related parameters | |
|---|---|---|---|---|---|---|
| Better than preTx | Worse than healthy control (HC) | |||||
| Segura-Saint-Gerons et al. [ | OHIP 49: 24.43 | n/a | n/a | n/a | Number of daily tooth-brushing, dental visits in previous year | Gender |
| Schmalz et al. [ | OHIP 14: 2.54 ± 3.68 | No (HD OHIP 14: 2.46 ± 4.68) | No (HC OHIP 14: 1.52 ± 2.71) | n/a | No | No |
| Schmalz et al. [ | OHIP 14: 1.70 ± 2.70 | n/a | No (HC OHIP 14: 1.54 ± 2.86) | n/a | No | No |
| Schmalz et al. [ | OHIP 14: 4.1 [1;0–5] | No (preLTx OHIP 14: 4.2 [1.5; 0–4.0] | Yes (HC OHIP 14: 1.4 [0; 0–2.0] | n/a | No | No |
| Ruokonen et al. [ | 75.1% maximum OHQS score | 71.5%* | n/a | Correlation 15D with OHQS | PPD, PIBI, TDI, number of teeth, UWS | n/a |
| Schmalz et al. [ | OHIP 14: 6.58 ± 6.40 | No (HF OHIP G14: 5.54 ± 5.47) | n/a | Correlation PCS and MCS of SF-36 with OHIP 14 | No | No |
| Oduncuoğlu et al. [ | OHIP 14: 8.9 ± 9.6; OHRQoL-UK: 44.8 ± 10.5 | Yes (HD OHIP 14: 12.28 ± 8.90) | no (HC OHIP 14: 9.0 ± 9.3) | n/a | n/a | Time since TX |
n/a not applicable, OHIP oral health impact profile, PCS physical compound summary, MCS mental compound summary, SF-36 short form 36 questionnaire, PPD periodontal probing depth, UWS unstimulated whole saliva, PIBI periodontal inflammatory burden index, TDI total dental index, OHQS oral health quality score, HD haemodialysis, LTx liver transplantation, HF heart failure, 15D 15D questionnaire
*No significance testing reported
Subscales of OHRQoL in the included studies. Because different questionnaires were used and several different options of subscales/dimensions exist, the available results are presented if available. The results are given as the mean values ± standard deviation or otherwise as percentages
| Author, year, disease | Functional limitation | Physical pain | Psycho-social discomfort | Physical disability | Psycho-logical disability | Social disability | Handicap | |
|---|---|---|---|---|---|---|---|---|
| Oduncuoğlu et al. KTx [ | 1.0 ± 1.5 | 1.7 ± 2.0 | 1.3 ± 1.9 | 1.0 ± 1.8 | 1.3 ± 1.7 | 1.7 ± 1.8 | 1.0 ± 1.5 | |
| Oral function | Psychosocial impact | |||||||
| Schmalz et al. HTx [ | 1.30 ± 2.40 | 2.04 ± 3.86 | ||||||
| Segura-Saint-Gerons et al. HTx [ | 6.5 ± 5.71 | 6.82 ± 6.72 | 3.42 ± 4.28 | 3.31 ± 5.04 | 2.31 ± 4.01 | 0.83 ± 2.34 | 1.24 ± 2.54 | |
OHIP oral health impact profile, KTx kidney transplantation, HTx heart transplantation
Fig. 2Change in the perception of the patients’ oral health situation due to the burden of SOT and related parameters, such as psychological, physical and social impairment
Fig. 3For sufficient, patient-oriented oral care of SOT recipients, a multidisciplinary team might be necessary to build awareness of the importance of healthy oral conditions